Sarcouncil Journal of Medicine and Surgery

Abstract: Aim The purpose of this study is to assess the safety and effectiveness of using the herbal anti-edema medication Aescin (Reparil) in conjunction with the α-blocker Tamsulosin as a medical expulsive treatment of distal ureteric stones. Patients and Procedures: In a prospective randomized controlled research, 100 patients having distal ureteral stones were divided into two therapy groups: 50 received Aescin (Reparil®) + Tamsulosin for two weeks, while the remaining 50 received Tamsulosin alone. Weekly patient follow-ups were conducted, and outcomes were documented. A successful response is characterized by total pain alleviation, a reduction in or elimination of PCS dilatation, and stone passing over the course of therapy. Findings: Both groups' pretreatment demographic information, including mean stone size, was equivalent. The mean time to stone ejection favored group A, although there was no significant distinction in the rate of stone expulsion (86% vs. 74%). Within the first week of therapy, there was a substantial difference in pain reduction favoring group A. Last but not least, group A benefited from a markedly distinct decline or elimination in PCS dilatation. Conclusion: In the MET of distal ureteric stones, the combination of the herbal anti-edema drug Aescin to α-blocker (Tamsulosin) seems to result in a considerable reduction in PCS dilatation, early pain relief, and a faster stone ejection.